Hot shot: the wider promise of weight-loss ja...

We examine the record of the man at the helm of India’s government. As protests pose a fresh threat, where will he take the country next? From New Hampshire to Virginia, our American-midterms series takes you to the races you might be missing. And the life of Winston Churchill’s ...  Show more

The world’s richest person does not say much nice about philanthropy, and his foundation does not say much about itself. Our correspondent digs deeper. The next stop for our midterm-elections series is Kansas, where a Republican-seeming Democrat has an unlikely shot at the Senate ...  Show more

Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ...  Show more

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Show more

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ...  Show more